News

Zegerid OTC is the OTC proton pump inhibitor (PPI) product with two active ingredients, omeprazole, a PPI, and sodium bicarbonate. The sodium bicarbonate acts as a buffer to

Hamamatsu said that the uCELL (micro cell) offers a cost-effective way for biotechnology companies, research institutes, and clinical research organizations to introduce advanced FDSS (Functional Drug Screening System)

Spectrum Pharmaceuticals posted a net income attributable to stockholders of $10.18m, or $0.20 per diluted share, compared to net loss of $8.87m, or $0.28 per diluted share, for

Reportedly, Dishman Pharmaceuticals has started construction at its proposed SEZ site, near Ahmedabad, Gujrat, India, in the last week of March, after receiving funds from IDBI and Bank

The randomised, double-blind, placebo-controlled study is expected to investigate the safety, tolerability and pharmacokinetic profile of NRM8499 in a group of up to 84 young and elderly healthy

The Sysmex XT-4000i provides 34 parameters, including the advanced clinical parameters, IG (Immature Granulocyte) and RET-He (Reticulocyte Hemoglobin Equivalent) and a Body Fluid specific mode. It utilizes Sysmex’s

Neuroges said that in November 2009, Qutenza was approved by the FDA for the management of neuropathic pain associated with PHN. Qutenza is the prescription-strength topical treatment for

Celsis claimed that LC-MS/MS allows the analysts to separate, quantify and identify elements in complex mixtures. The testing method works by using HPLC to initially separate the compounds,

Ser-120 is a new, nasally administered clinical drug candidate in Phase III clinical trials being investigated for its safety and efficacy in relieving the symptoms of nocturia and